Functional dyspepsia (FD) and gastroparesis (GP) are clinically managed as distinct upper gastrointestinal conditions but present with symptoms that are often indistinguishable. FD is a common disorder of gut-brain interaction that negatively impacts quality of life, while GP is considered a rare disease exclusively defined by delayed gastric emptying and symptoms. The degree of overlap between these disorders makes them hard to differentiate in clinical practice, thereby impacting treatment decisions. This review is focused on exploring the similarities and differences between FD and GP to guide clinician management and improve treatment outcomes. A comprehensive literature search was performed and the full texts of eligible articles were retrieved for the extraction of information reported in this review. This summary of evidence supports the hypothesis that GP and FD represent two ends of the same disease spectrum in a major subgroup. Improved understanding of the similarities, differences and overlap is likely to help guide the development of objective biomarkers and better-targeted therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770444 | PMC |
http://dx.doi.org/10.1136/egastro-2024-100119 | DOI Listing |
Actas Esp Psiquiatr
March 2025
Department of Gastroenterology, Gong An County People's Hospital, 434300 Jingzhou, Hubei, China.
Objective: This study aimed to explore the factors influencing sleep disorders in patients with functional dyspepsia.
Methods: A total of 100 patients with functional dyspepsia admitted to Gong An County People's Hospital from 2020 to 2021 were selected. According to the Pittsburgh Sleep Quality Index (PSQI), those with a score ≥8 were classified as the occurrence group, whereas those with a score <8 were classified as the non-occurrence group.
Front Med (Lausanne)
February 2025
School of Acupuncture-Moxibustion, Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha, China.
Background: Postprandial distress syndrome (PDS) is the prominent subtype in patients with functional dyspepsia (FD) and currently lacks a satisfactory treatment. Acupuncture has become a promising alternative and complementary therapy for managing FD. However, high-level clinical evidence supporting the use of acupuncture for FD is limited.
View Article and Find Full Text PDFDig Dis Sci
March 2025
Gastroenterology, Gastromedical "Regional Gastroenterology and Advanced Endoscopy Unit", Mexicali, Baja California, Mexico.
Background: Dyspepsia, characterized by symptoms in the gastroduodenal region, poses diagnostic challenges despite Rome IV criteria.
Aim: This study aimed to investigate the prevalence of two underreported symptoms, Empty Stomach Sensation and Bothersome Hunger Sensation, in dyspeptic patients, and their association with the disorder of gut-brain interaction.
Methods: A cross-sectional study surveyed 1,211 individuals in northwest Mexico, assessing dyspeptic symptoms with pictograms and a 7-point Likert scale.
Neurogastroenterol Motil
March 2025
Department of Medicine, Cedars-Sinai, Los Angeles, California, USA.
Background: We hypothesized that disorders of gut-brain interaction (DGBI) increased during the pandemic due to the enteropathic nature of SARS-CoV-2, together with the potential for COVID-19 pandemic-related stress to negatively impact the gut-brain axis. To test our hypothesis, we conducted a series of pre-specified cross-sectional surveys initiated at the beginning of the pandemic to trend the prevalence of Rome IV DGBI over time among a nationally representative sample of more than 160,000 people in the US.
Methods: From May 2020 to May 2022, we performed a series of cross-sectional online surveys among a representative sample of adults ≥ 18 years old in the US.
Neurogastroenterol Motil
March 2025
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Background & Aims: Disorders of gut-brain interaction (DGBI) in obesity could impair health outcomes. Therefore, we aimed to study the prevalence and burden of symptoms compatible with a DGBI in obesity and assess the effect of obesity treatment on comorbid DGBI.
Methods: We used baseline and two-year follow-up data from a prospective non-randomized cohort study including patients with obesity referred for obesity treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!